Loading clinical trials...
Loading clinical trials...
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Conditions
Interventions
TactiCath SE
Locations
21
United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Scripps Health
La Jolla, California, United States
Sequoia Hospital
Redwood City, California, United States
South Denver Cardiology Associates, P.C.
Littleton, Colorado, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Florida Hospital
Orlando, Florida, United States
Start Date
December 11, 2017
Primary Completion Date
August 2, 2018
Completion Date
October 30, 2019
Last Updated
October 11, 2023
NCT07421076
NCT07281898
NCT05988411
NCT06765356
NCT06106594
NCT06021808
Lead Sponsor
Abbott Medical Devices
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions